Daoud Research Group, Khartoum, Sudan.
Department of Internal Medicine, University of Khartoum, Khartoum, Sudan.
Am J Drug Alcohol Abuse. 2022 May 4;48(3):328-333. doi: 10.1080/00952990.2021.2024559. Epub 2022 Feb 7.
People who inject drugs (PWID) are at high risk of contracting blood-borne infections. Many developed countries started a needle exchange program to provide PWID with sterile syringes. In Sudan, healthcare professionals are exposed to legal liability if they cooperate with people who use drugs; therefore, the accessibility to sterile syringes without prescription depends heavily on pharmacists' knowledge and attitude toward PWID. Assessing policy, practice, and perceptions of pharmacists toward selling sterile syringes to PWID in Khartoum, Sudan. A self-administered questionnaire was given to 157 pharmacists (57 male, 100 female). Out of 157 participating pharmacists, 86.6% reported selling syringes without a medical prescription, 53.5% inquired about the reason for buying syringes, and 87.9% refused to sell the syringes to a PWID. 43.3% of participating pharmacists were uncertain about the presence of law to regulate selling syringes without prescriptions. Although 47.7% of the participants agreed that selling empty syringes without a medical prescription to PWID will reduce harm, 68.5% will not sell them to PWID without a medical prescription even if it is encouraged by law due to their religious or moral beliefs. Pharmacists are the main providers of clean syringes for PWID in Khartoum, Sudan. With the majority of them reporting refusal to provide syringes to PWID, this may put PWID at higher risk of contracting blood-borne infections due syringe sharing. This is a challenge to overcome in planning for effective harm reduction programs in Khartoum.
注射毒品者(PWID)感染血源性病原体的风险很高。许多发达国家开始实施针具交换计划,为 PWID 提供无菌注射器。在苏丹,医疗保健专业人员如果与吸毒者合作,将承担法律责任;因此,无需处方获得无菌注射器的机会在很大程度上取决于药剂师对 PWID 的知识和态度。评估政策、实践和药剂师对在苏丹喀土穆向 PWID 出售无菌注射器的看法。向 157 名药剂师(57 名男性,100 名女性)发放了一份自我管理问卷。在参与的 157 名药剂师中,86.6%报告说无需处方即可出售注射器,53.5%询问购买注射器的原因,87.9%拒绝向 PWID 出售注射器。43.3%的参与药剂师不确定是否有法律规定无需处方即可出售注射器。尽管 47.7%的参与者认为向 PWID 出售无处方的空注射器将减少伤害,但由于他们的宗教或道德信仰,即使法律鼓励,仍有 68.5%的人不会向 PWID 出售无处方的注射器。药剂师是喀土穆 PWID 的主要清洁注射器提供者。由于大多数药剂师拒绝向 PWID 提供注射器,这可能会使 PWID 因共用注射器而面临更高的感染血源性感染的风险。这是在喀土穆规划有效减少伤害计划时需要克服的挑战。